Fresenius Medical Care AG & Co. KGaA Market Cap ($9.88 Billion)
Market Cap & Net Worth: Fresenius Medical Care AG & Co. KGaA (FMEA)
Fresenius Medical Care AG & Co. KGaA market cap. Fresenius Medical Care AG & Co. KGaA (F:FMEA) has a market capitalization of $9.88 Billion (€8.45 Billion) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #2189 globally and #466 in its home market, demonstrating a 6.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fresenius Medical Care AG & Co. KGaA's stock price €20.40 by its total outstanding shares 537129260 (537.13 Million). Also see FMEA operating cash flow for how efficiently the company converts equity into cash flow.
Fresenius Medical Care AG & Co. KGaA Market Cap History (2015–2026)
Fresenius Medical Care AG & Co. KGaA market cap history from 2015 to 2026. Data shows change from $19.17 Billion to $12.81 Billion (-3.25% CAGR). Check Fresenius Medical Care AG & Co. KGaA stock quote for real-time trading data and today's change.
Fresenius Medical Care AG & Co. KGaA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fresenius Medical Care AG & Co. KGaA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Fresenius Medical Care AG & Co. KGaA net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.64x
Fresenius Medical Care AG & Co. KGaA's market cap is 0.64 times its annual revenue
Latest Price to Earnings (P/E) Ratio
12.77x
Fresenius Medical Care AG & Co. KGaA's market cap is 12.77 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $20.06 Billion | $17.03 Billion | $1.18 Billion | 1.18x | 16.97x |
| 2017 | $22.01 Billion | $17.78 Billion | $1.28 Billion | 1.24x | 17.20x |
| 2018 | $14.59 Billion | $16.55 Billion | $1.98 Billion | 0.88x | 7.36x |
| 2019 | $17.39 Billion | $17.48 Billion | $1.20 Billion | 1.00x | 14.50x |
| 2020 | $18.18 Billion | $17.86 Billion | $1.16 Billion | 1.02x | 15.61x |
| 2021 | $16.27 Billion | $17.62 Billion | $969.00 Million | 0.92x | 16.79x |
| 2022 | $8.87 Billion | $19.40 Billion | $673.00 Million | 0.46x | 13.18x |
| 2023 | $11.38 Billion | $19.45 Billion | $499.00 Million | 0.58x | 22.80x |
| 2024 | $13.82 Billion | $19.34 Billion | $537.91 Million | 0.71x | 25.68x |
| 2025 | $12.50 Billion | $19.63 Billion | $978.37 Million | 0.64x | 12.77x |
Competitor Companies of FMEA by Market Capitalization
Companies near Fresenius Medical Care AG & Co. KGaA in the global market cap rankings as of November 1, 2026. Also see FMEA asset base for a full breakdown of the balance sheet.
Key companies related to Fresenius Medical Care AG & Co. KGaA by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of Fresenius Medical Care AG & Co. KGaA (2015–2026)
Market capitalization of Fresenius Medical Care AG & Co. KGaA from 2015 to today. Between 2015 and today, Fresenius Medical Care AG & Co. KGaA's market cap moved from $19.17 Billion to $ 12.81 Billion, with a yearly change of -3.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €12.81 Billion | +2.51% |
| 2025 | €12.50 Billion | -9.55% |
| 2024 | €13.82 Billion | +21.42% |
| 2023 | €11.38 Billion | +28.22% |
| 2022 | €8.87 Billion | -45.45% |
| 2021 | €16.27 Billion | -10.52% |
| 2020 | €18.18 Billion | +4.51% |
| 2019 | €17.39 Billion | +19.22% |
| 2018 | €14.59 Billion | -33.71% |
| 2017 | €22.01 Billion | +9.74% |
| 2016 | €20.06 Billion | +4.63% |
| 2015 | €19.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Fresenius Medical Care AG & Co. KGaA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.88 Billion USD |
| MoneyControl | $9.88 Billion USD |
| MarketWatch | $9.88 Billion USD |
| marketcap.company | $9.88 Billion USD |
| Reuters | $9.88 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more